Savvy Psychopharmacology

Savvy Psychopharmacology

Effects of psychotropic medications on thyroid function

Ms. L, age 53, presents to an inpatient psychiatric unit with depression, difficulty concentrating, fatigue, cognitive blunting, loss of appetite...

Savvy Psychopharmacology

Serotonin syndrome: How to keep your patients safe

Mr. S, age 55, comes to your clinic as a walk-in for management of major depressive disorder, insomnia, and migraines. He also has tobacco use...

Savvy Psychopharmacology

Pharmacogenomics testing: What the FDA says

Although psychiatrists have gained more experience implementing pharmacogenomics testing in practice, confusion still exists regarding how to best...

Savvy Psychopharmacology

Psychotropic-induced hyponatremia

Hyponatremia is a common, multifactorial clinical condition. Hyponatremia is usually defined as a plasma sodium level <135 mmol/L; however,...

Savvy Psychopharmacology

Managing procedural pain in a patient taking naltrexone

Mr. M, age 55, presents to his primary care physician (PCP) with hematochezia. Mr. M states that for the past week, he has noticed blood upon...

Savvy Psychopharmacology

Making sense of CYP2D6 and CYP1A2 genotype vs phenotype

The clinical response to the same dose of a drug may vary among individuals. Cytochrome P450 (CYP) 2D6 and 1A2 are enzymes that metabolize many...

Savvy Psychopharmacology

Treating psychosis in patients with HIV/AIDS

Mr. S, age 56, has human immunodeficiency virus (HIV) and schizoaffective disorder.

Pages